Globally, mosquitoes are the primary vectors of disease, infecting over 400 million people and causing approximately 40,000 deaths annually. A new study has found that one species of mosquito, Aedes aegypti, which transmits various diseases including dengue fever, Zika virus, and yellow fever, has developed resistance to one of the world’s most commonly used insecticides for disease control. The researchers also discovered the driving force behind this resistance: a protein that replicates after exposure to the insecticide. The team stated that understanding mosquitoes’ internal defense mechanisms before they fully develop resistance is key to controlling the spread of disease.
Traditionally, public health programs have relied on chemical pesticides to control mosquitoes, which may be one reason why mosquito control is becoming increasingly difficult. Over time, pesticides can cause biochemical and genetic mutations in mosquitoes, giving certain mosquito populations a survival advantage.
In a new study published in the journal Frontiers in Tropical Diseases, researchers from India examined the mechanisms of resistance to α-cypermethrin, a widely used insecticide for disease vector control worldwide.
”We found that mortality rates in the Aedes aegypti mosquito population in India reached 97.91% after exposure to the recommended diagnostic dose of cypermethrin. This suggests that these mosquitoes may be developing resistance to this insecticide,” said Dr. Rohit Lakhwani, the study’s first author and a research fellow at the University of Delhi.
”Understanding the biological mechanisms of mosquito survival during the early stages of insecticide resistance development is crucial,” added Dr. Salita Kumar, lead author of the study and a professor in the Department of Zoology at Delhi University.
Insects contain detoxifying enzymes—proteins they produce naturally to protect themselves from toxic substances—that typically begin to work within a few hours of exposure.
”When the insecticide enters the mosquito’s body, it activates the cellular signaling system. This triggers a series of reactions in the insect’s cells and accelerates the production of protective proteins,” Kumar explained.
The detoxifying enzyme binds to the pesticide molecule, breaking the molecular bond and leaving behind less harmful compounds that are more easily eliminated from the body.
The research team selected five detoxification enzymes previously identified as key detoxification mechanisms. They used the World Health Organization bioassay (exposing live mosquitoes to diagnostically relevant concentrations of pesticides), molecular docking (a computer-aided analysis method used to predict the binding affinity of pesticides to detoxification enzymes), and biochemical analysis to identify differences in the levels of various detoxification enzymes across mosquito populations.
The researchers found that β-esterases—enzymes that specifically break down certain compounds commonly found in insecticides such as α-cypermethrin—responded most strongly to the insecticides. Their activity increased more than 21-fold after exposure to the insecticide, and they bound very tightly to the insecticide molecules. This suggests that this enzyme is the primary mechanism by which mosquitoes defend themselves against α-cypermethrin.
Other enzymes involved in the study also made significant contributions to the detoxification process. CYP450 is a pluripotent enzyme capable of reacting to a variety of foreign chemicals, while GST is responsible for attaching protective molecules to toxic compounds; their reactivity ranked second and third, respectively.
”This means that when mosquitoes are threatened, they can significantly increase production of a particularly effective enzyme. Other enzymes exhibit broader activity against many different toxins, but may not be the best choice for this particular insecticide,” Kumar said.
The effectiveness of detoxifying enzymes in combating pesticide molecules is limited, which explains the weaker response of some of them.
Although these mosquitoes showed early signs of resistance to cypermethrin, they did not develop sustained resistance. The research team stated that this is, in fact, a worrying sign. Of particular note is the potential for cross-resistance between mosquitoes and insecticides with similar mechanisms of action.
Kumar said, “Because resistance develops at different rates, it is impossible to predict when resistance will spread to the point where α-cypermethrin becomes ineffective. Biochemical resistance can also be reversible if a particular insecticide is no longer used.”
Mosquito populations can exhibit significant differences in pesticide resistance depending on the duration of pesticide use in a given region, environmental conditions, and local vector control measures. Therefore, mosquitoes in some countries may be more resistant to lambda-cyhalothrin than those in India.
There are several ways to overcome the effects of detoxifying enzymes, such as using inhibitors to block the defense system. Rotating insecticides can also limit the development of resistance, preventing it from occurring. Eliminating mosquito breeding sites and using biological control methods help maintain the effectiveness of existing insecticides and improve long-term control results.
The research team noted that their findings apply only to laboratory-reared populations of Aedes aegypti mosquitoes at a specific point in time, and resistance levels may vary in other populations, regions, or natural settings. Nevertheless, the study consistently identified β-esterase as the key enzyme involved in the detoxification of α-cypermethrin.
Kumar concluded: “The value of our study lies not only in demonstrating the existence of resistance, but also in helping to explain how resistance arises at the molecular level. Crucially, this resistance has not yet become widespread. This allows health departments to implement resistance management strategies before pesticides become completely ineffective.”
Reprint Policy: Open access to research results and their dissemination are among the missions of Frontiers journal. Unless otherwise noted, you may reprint articles published on the Frontiers news site, but you must provide a link to the original research. Selling these articles is prohibited.
Post time: Aug-18-2026
